
Harnessing Genetic Testing to Unravel the Mysteries of Hydrops Fetalis
Explore how genetic testing, especially whole-exome sequencing, unveils causes of non-immune hydrops fetalis, enhancing diagnosis, prenatal care, and family planning.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing, especially whole-exome sequencing, unveils causes of non-immune hydrops fetalis, enhancing diagnosis, prenatal care, and family planning.

Explore how genetic testing aids in diagnosing and managing Hyperphenylalaninemia due to BH4 deficiency, enabling early intervention and personalized treatment.

Explore how genetic testing, especially next-generation sequencing, aids in diagnosing idiopathic camptocormia, offering personalized treatment and family planning options.

Explore how genetic testing aids in diagnosing Immunodeficiency due to a late component of complement deficiency, guiding personalized treatment and family planning.

Explore how genetic testing aids in early diagnosis, personalized treatment, and family planning for infantile bilateral striatal necrosis (IBSN).

Explore how genetic testing, focusing on PDGFRB and NOTCH3 mutations, aids in diagnosing infantile myofibromatosis, guiding treatment and family planning.

Genetic testing aids in early detection, management, and counseling for isolated anophthalmia-microphthalmia syndrome, improving outcomes for affected individuals.

Explore the role of genetic testing in diagnosing and treating isolated ectopia lentis, enhancing accuracy, personalized care, and guiding family planning decisions.